Controlled release therapeutic wound dressings
View Patent ↗A wound dressing comprising: a therapeutic agent selected from the group consisting of antimicrobial substances, pain relieving substances, protease inhibitors, and mixtures thereof; and a barrier layer for initially separating the therapeutic agent from a wound fluid in use, wherein the barrier layer comprises a substrate for an enzyme selected from the group consisting of proteases, kallikrein and tissue-plasminogen activator. Preferably the substrate comprises a substrate for elastase or a collagenase. The barrier layer breaks down in infected or chronic wounds, thereby releasing the therapeutic substance selectively into such wounds.
1. A wound dressing comprising:
a therapeutic agent selected from the group consisting of antimicrobial substances, pain relieving substances, protease inhibitors, and mixtures thereof; and
a wound contacting barrier layer for initially separating the therapeutic agent from a wound fluid, said barrier layer comprising a substrate for an enzyme from an infected or chronic wound selected from the group consisting of proteases, kallikrein and tissue- plasminogen activator,
wherein said barrier layer is substantially free of the therapeutic agent, is substantially impervious to and insoluble in wound fluid free of said enzyme and, in use, separates said therapeutic agent from said wound fluid until and unless said substrate is broken down by said enzyme from an infected or chronic wound.
2. The wound dressing according to claim 1 , wherein the therapeutic substance comprises an antiseptic, an antibiotic, an analgesic, a local anaesthetic, a protease inhibitor, or mixtures thereof.
3. The wound dressing according to claim 2 , wherein the therapeutic substance comprises an antiseptic selected from the group consisting of chlohexidine, silver sulfadiazine, povidone iodine, silver salts, triclosan, sucralfate, quaternary ammonium salts, and mixtures thereof.
4. The wound dressing according to claim 2 , wherein the therapeutic substance comprises an antibiotic selected from the group consisting of tetracycline, penicillins, terramycins, erythromycin, bacitracin, neomycin, polymycin B, mupirocin, clindamycin and mixtures thereof.
5. The wound dressing according to claim 1 , further comprising a liquid-impermeable backing layer over the therapeutic substance and the barrier layer.
6. The wound dressing according to claim 5 , wherein the backing layer is adhesive-coated and provides an adhesive-coated margin around the therapeutic substance and the barrier layer.
7. The wound dressing according to claim 1 , further comprising an absorbent layer.
8. The wound dressing according to claim 1 , wherein the barrier layer comprises a substantially continuous film comprising the substrate material.
9. The wound dressing according to claim 1 , wherein the barrier layer comprises an apertured sheet having a composition comprising the substrate material applied thereto in occlusive fashion.
10. The wound dressing according to claim 8 or 9 , wherein a layer of the therapeutic substance is provided behind the barrier layer.
11. The wound dressing according to claim 10 , wherein an absorbent layer is provided behind the barrier layer and the therapeutic substance is dispersed in the absorbent layer.
12. The wound dressing according to any one of claims 1 to 7 , wherein the barrier layer substantially encapsulates the therapeutic substance.
13. The wound dressing according to any one of claims 1 to 9 , wherein the substrate material comprises a substance selected from the group consisting of elastin, fibronectin, collagen, crossliniked gelatin, fibrinogen, casein, hyaluronic acid, plasminogen, fibrin, and mixtures thereof.
14. The wound dressing according to claim 10 , wherein the substrate material comprises a substance selected from the group consisting of elastin, fibronectin, collagen, crossliniked gelatin, fibrinogen, casein, hyaluronic acid, plasminogen, fibrin, and mixtures thereof.
15. The wound dressing according to claim 11 , wherein the substrate material comprises a substance selected from the group consisting of elastin, fibronectin, collagen, crossliniked gelatin, fibrinogen, casein, hyaluronic acid, plasminogen, fibrin, and mixtures thereof.
16. The wound dressing according to claim 12 , wherein the substrate material comprises a substance selected from the group consisting of elastin, fibronectin, collagen, crossliniked gelatin, fibrinogen, casein, hyaluronic acid, plasminogen, fibrin, and mixtures thereof.
17. A method for treating a wound, comprising providing a wound dressing according to claim 1 , and topically applying it to a wound.